Connect with us

News

“No evidence” to suggest cannabis leads to decline in cognitive ability

Data was taken from over 800 adolescents 

Published

on

There was “no evidence to support the presumption that cannabis consumption leads to a decline in neurocognitive ability.”

Researchers investigating cannabis use in teenagers, say it has no significant residual effect on how the brain functions.

Researchers have conducted one of the largest longitudinal European studies examining the effects of cannabis on the cognitive abilities in teenagers. 

Their findings suggest that decision-making is not impaired when it is used in moderation, and when first use is after the age of 15.

Beyond that, there was “no evidence to support the presumption that cannabis consumption leads to a decline in neurocognitive ability.”

Data was collected from over 800 adolescents at the age of 14 and 19.

A cross-sectional analysis was conducted, which found that there were “no significant neurocognitive differences before initiation of drug use”.

After controlling for variables, light cannabis use and late-onset of consumption was actually associated with “increased decision-making skills both cross-sectionally at follow-up.”

The authors concluded: “Our data suggests that decision-making is not impaired when cannabis is used in moderation and onset of use occurs after the age of 15. In addition, we find no evidence to support the presumption that cannabis consumption leads to a decline in neurocognitive ability.”

The effects of cannabis on cognition in teenagers have been unclear, with a 2019 review finding that regular cannabis users display poorer neurocognitive functioning relative to non-users, regardless of age. 

However, a recently-published study from the US, which followed more than 300 pairs of identical twins who consumed different levels of cannabis, from age 11 also found it did not lead to cognitive or mental health problems in adulthood. 

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.